Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review
Qingmin Zeng, Changhai Liu, Dongbo Wu, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 560-560
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases
Arianna Ferro, Gabriele Saccu, Simone Mattivi, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 277-277
Open Access | Times Cited: 13
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 40-40
Open Access | Times Cited: 12
Influence of the lncRNA SLC9A3-AS1 on colon cancer and the biological activities of colon cancer cells
Xiulian Xu, Huiguo Qing, Chunyan Jiang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome
Fan Yang, Leyu Zhou, Yi Shen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Cracking the code: lncRNA-miRNA-mRNA integrated network analysis unveiling lncRNAs as promising non-invasive NAFLD biomarkers toward precision diagnosis
Nouran Yonis, Ahmed Mousa, Mohamed H. Yousef, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108325-108325
Closed Access
Oxidative stress-induced circSOD2 inhibits osteogenesis through sponging miR-29b in metabolic-associated fatty liver disease
LI Liang-ping, Xiaoying Chen, Hongbo Liu, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 9
Closed Access
Plasma‐Derived Neuronal Exosomal CircRNAs as Potential Biomarkers for Central Nervous System Infections
Rui Zhang, Beng-Ning Deng, S. Shi, et al.
Journal of Immunology Research (2025) Vol. 2025, Iss. 1
Open Access
Identification and Assessment of lncRNAs and mRNAs in PM2.5-Induced Hepatic Steatosis
Peng Tian, Hui Xia, Xin-Bao Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2808-2808
Open Access
Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD
Moeka Nakashima, Naoko Suga, Yuka Ikeda, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 1, pp. 11-11
Open Access | Times Cited: 3
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Efthymios P. Tsounis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12864-12864
Open Access | Times Cited: 9
The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression
Valerio Caputo, Giovanni Tarantino, Silvano Junior Santini, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4757-4757
Open Access | Times Cited: 8
Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
Samar A. Zailaie, Basmah B. Khoja, Jumana J. Siddiqui, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 1, pp. 10-10
Open Access | Times Cited: 2
lincRNA00907 promotes NASH progression by targeting miRNA-942-5p/TAOK1
Gang Du, Zhaochen Jiang, Tong Xia, et al.
Aging (2024)
Open Access | Times Cited: 2
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Mitrică, et al.
Metabolites (2023) Vol. 13, Iss. 11, pp. 1115-1115
Open Access | Times Cited: 5
Long Noncoding RNAs in Diet-Induced Metabolic Diseases
Annette Brandt, Florian Kopp
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5678-5678
Open Access | Times Cited: 1
Core competing endogenous RNA network based on mRNA and non‐coding RNA expression profiles in chicken fatty liver
Qingxing Xiao, Yonghong Zhang, Hongyu Ni, et al.
Animal Genetics (2024) Vol. 55, Iss. 5, pp. 772-778
Closed Access | Times Cited: 1
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis
Henry Wade, Kaichao Pan, Bingrui Zhang, et al.
eGastroenterology (2024) Vol. 2, Iss. 4, pp. e100115-e100115
Open Access | Times Cited: 1
Expression level of long non-coding RNA MALAT1, GAS5, DANCR and TUG1 in peripheral blood leukocytes of patients with non-alcoholic fatty liver disease
И. В. Курбатова, Alina Vasileva, Л. В. Топчиева, et al.
Experimental and Clinical Gastroenterology (2024), Iss. 10, pp. 160-167
Open Access
A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes
Manvita Mareboina, Elen Deng, Ioannis Mouratidis, et al.
Molecular Metabolism (2024) Vol. 87, pp. 101987-101987
Open Access
The Role of the MiR-181 Family in Hepatocellular Carcinoma
Jinbiao Chen, Ken Liu, Mathew A. Vadas, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1289-1289
Open Access
Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism
Zhicheng Li, Dan Wang, Xiaojun Zhu
Clinical & Translational Oncology (2024)
Closed Access
Non-Coding RNAs Involved in the Regulation of Signaling Pathways as Possible Markers of Non-Alcoholic Fatty Liver Disease Progression
Л. В. Топчиева, И. В. Курбатова, О. П. Дуданова, et al.
Biology Bulletin (2024) Vol. 51, Iss. 5, pp. 1271-1290
Closed Access
Evaluating the therapeutic potential of genetically engineered probiotic Zbiotics (ZB183) for non-alcoholic steatohepatitis (NASH) management via modulation of the cGAS-STING pathway
Maha Saad, Walaa Ibrahim, Amany Helmy Hasanin, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Targeting Long Non-Coding RNA H19 as a Therapeutic Strategy for Liver Disease.
Yulan Shi, F. Qu, Shiyun Zeng, et al.
Progress in Biophysics and Molecular Biology (2024)
Closed Access
The role of macrophage-derived exosomes in noncancer liver diseases: From intercellular crosstalk to clinical potential
Xiaoli Fan, Jin Lin, Honglan Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113437-113437
Closed Access
Page 1 - Next Page

Scroll to top